First guidelines for the treatment of LM disease issued by SOLACI and SIAC

PCR Perspectives

Summary

During EuroPCR 2025, Cleverson Zukowski and Pablo Lamelas introduce a landmark initiative: the first clinical guidelines for left main disease specifically developed for Latin America.

Published by the Latin American Society of Interventional Cardiology (SOLACI) and the Interamerican Society of Cardiology (SIAC), these recommendations aim to support decision-making between PCI and surgery by taking into account the specific realities of the region.

Why were these guidelines needed? What are their key messages? And how can they be translated into daily practice?

Watch this interview to explore a tailored approach to left main revascularisation in Latin America.

This interview was filmed at EuroPCR 2025: see more videos here.

Also available in podcast format:

This podcast is also available on Spotify and Apple Podcasts